# Regulus Therapeutics Inc.: Form D filings

Regulus Therapeutics Inc., a pharmaceuticals company in San Diego, CA, filed 9 Form D notices with the SEC between 2010 and 2021. The latest, on December 6, 2021, reports $34.6 million sold of a $34.6 million offering to 16 investors.

Find out what Regulus Therapeutics Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Regulus%20Therapeutics%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Regulus%20Therapeutics%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fregulus-therapeutics-inc-1505512)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Regulus%20Therapeutics%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Regulus%20Therapeutics%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fregulus-therapeutics-inc-1505512)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 4224 CAMPUS POINT COURT, SUITE 210, San Diego, CA, 92121
- Phone: (858) 202-6300
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1505512

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Dec 6, 2021 | New notice | $34,624,999 | $34,624,999 | $0 | 16 | Nov 30, 2021 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1505512/000172479221000001/0001724792-21-000001-index.htm) |
| Dec 17, 2020 | New notice | $34,537,555 | $19,383,037 | $15,154,518 | 18 | Dec 4, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1505512/000175942520000001/0001759425-20-000001-index.htm) |
| May 14, 2019 | New notice | $79,343,959 | $16,736,889 | $62,607,070 | 21 | May 7, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1505512/000116998719000001/0001169987-19-000001-index.htm) |
| Feb 6, 2014 | New notice | $9,999,992 | $9,999,992 | $0 | 1 | Feb 4, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1505512/000150551214000001/0001505512-14-000001-index.htm) |
| Oct 23, 2012 | New notice | $5,000,000 | $5,000,000 | $0 | 1 | Aug 15, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1505512/000150551212000003/0001505512-12-000003-index.htm) |
| Oct 23, 2012 | New notice | $25,000,000 | $25,000,000 | $0 | 1 | Oct 10, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1505512/000150551212000002/0001505512-12-000002-index.htm) |
| Nov 15, 2010 | New notice | $9,999,996 | $9,999,996 | $0 | 1 | Oct 27, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1505512/000150551210000003/0001505512-10-000003-index.htm) |
| Nov 15, 2010 | New notice | $20,000,000 | $20,000,000 | $0 | 2 | Mar 3, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1505512/000150551210000002/0001505512-10-000002-index.htm) |
| Nov 15, 2010 | New notice | $29,800,000 | $29,800,000 | $0 | 2 | Jan 2, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1505512/000150551210000001/0001505512-10-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Joseph Hagan | Executive Officer, Director |  |
| Christopher Aker | Executive Officer |  |
| Alice S. Huang | Director |  |
| Cris Calsada | Executive Officer |  |
| Jake R. Nunn | Director |  |
| David Baltimore | Director |  |
| Denis Drygin | Executive Officer |  |
| William H. Rastetter | Director |  |
| Pascale H. Witz | Director |  |
| Kathryn J. Collier | Director |  |
| Stelios Papadopoulos | Director |  |
| Simos H. Simeonidis | Director |  |
| Hugh H. Rosen | Director |  |

## Other pharmaceuticals companies in California that filed recently

- [Anvion Bio, Inc.](https://specstream.ai/data/form-d/company/anvion-bio-inc-2158000) $100,000 · Oct 7, 2026
- [Aqur Biosciences, Inc.](https://specstream.ai/data/form-d/company/aqur-biosciences-inc-2094075) $1.5 million · Sep 18, 2026
- [BTB Therapeutics, Inc.](https://specstream.ai/data/form-d/company/btb-therapeutics-inc-2055053) $8.9 million · Aug 12, 2026

[Every Form D from the week of Dec 6, 2021](https://specstream.ai/data/form-d/week/2021-12-06) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Regulus Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).